|
Leprosy
Situation in India
November
2005
The
sources of the data presented in this report are from the Central Leprosy
Division, Government of India. The figures are from the end October 2005
 Introduction
As at the end of October 2005 the Prevalence Rate
(PR) for the country stood at 1.15 per ten thousand population. 128,336
patients were under treatment at that point of time and 107,726 new patients
had been detected in the country since first of April 2005.The MB proportion
stood at 45.85%, Child Rate at 10.34% and Deformity Rate 1.69% of new case
detected. The overall trends could be commented upon as satisfactory with
scope for improvement. Prevalence rate at the end of November 2005 is 1.06
per ten thousand population.
Leprosy Prevalence Rate in India, April 2005 - October 2005
November 2005 India
|
The Prevalence
Rate
|
1.06 per ten
thousand population
|
|
MB Proportion
|
45.83% of new
case detected
|
|
Female
Proportion
|
32.67% of new
case detected
|
|
Child
Proportion
|
10.19% of new
cases detected
|
|
Visible (Grade
II) Deformity proportion
|
1.69% of new
cases detected
|
State Situation
Recently Goa has
joined the list of states which have achieved elimination, leaving only
eleven states / UTs with a prevalence of over one per ten thousand population
out of a total thirty five states / UTs. However in Madhya Pradesh PR has
moved to just over one. A WHO NLEP Coordinator has been immediately moved
into the state and initial reports signify that the problem lies with
inappropriate record keeping. Attention is now being focused on the states
which have attained elimination but still have a large number of cases.
Rajasthan, Andhra Pradesh, Tamil Nadu and Gujarat
are under renewed attention. In Rajasthan register updating removed a large
number of cases recently which were inappropriately continuing in the
registers (against WHO / GOI Guidelines) and more such deletions are
expected. Plans for augmenting the quality of anti leprosy services both in
endemic and non endemic states by means of enhancing monitoring, training of
personnel, development of referral systems and improvement of Prevention of
Impairments and Disabilities (POID) services are being implemented.
WHO
Support
WHO stands firm on its commitment for full support
to India‘s efforts to achieve elimination. MDT drug supply (free of charge)
is promised up to 2010. The present pattern of technical support both to the
Central Leprosy Division and the State Health departments as well as to
various academic and research institutions is expected to continue. Seventeen
WHO NLEP Coordinators will continue to function in the various states to
further improve the leprosy scenario and consolidate the gains acquired in
the year 2006.
|
